Plasmanate and hepatic function abnormal Patient Reports February 13, 2012

Plasmanate Side Effects Report #5794407-8
Plasmanate side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2008. Male patient, 63 years of age, weighting 136.7 lb, was diagnosed with hypoalbuminaemia, sepsis  and was treated with Plasmanate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, hepatitis b e antigen positive, hepatitis b surface antigen positive. Plasmanate dosage: 250 ML; IV. During the same period patient was treated with ALBUMIN, VENOGLOBULIN. Patient was hospitalized. Patient recovered.